59691-15-5 Usage
Uses
Used in Pharmaceutical Industry:
3-amino-4-propoxybenzoic acid serves as a crucial intermediate in the synthesis of various medications. Its unique structure, which includes a benzene ring with an attached propoxy group, an amino group, and a carboxylic acid group, allows it to be a component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Organic Chemistry:
As a building block in organic chemistry, 3-amino-4-propoxybenzoic acid is utilized in the synthesis of complex organic molecules. Its functional groups enable it to participate in a wide range of chemical reactions, making it a valuable component in the creation of novel organic compounds.
Used in Polymer Production:
3-amino-4-propoxybenzoic acid may also find applications in the production of polymers. Its chemical structure can be incorporated into polymer chains, potentially influencing the properties of the resulting polymers, such as their solubility, stability, or reactivity.
Used as a Chemical Reagent:
In the realm of organic synthesis, 3-amino-4-propoxybenzoic acid can act as a chemical reagent. Its ability to participate in various chemical reactions makes it a useful tool for chemists in the synthesis of a broad spectrum of organic compounds.
Overall, 3-amino-4-propoxybenzoic acid is a multifaceted compound with a broad range of potential applications across the fields of chemistry and pharmaceuticals, underscoring its importance in both research and industrial settings.
Check Digit Verification of cas no
The CAS Registry Mumber 59691-15-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,6,9 and 1 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 59691-15:
(7*5)+(6*9)+(5*6)+(4*9)+(3*1)+(2*1)+(1*5)=165
165 % 10 = 5
So 59691-15-5 is a valid CAS Registry Number.
59691-15-5Relevant academic research and scientific papers
S1P RECEPTORS MODULATORS
-
Page/Page column 111, (2010/04/30)
The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as cancer.
